FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine and deals with a method of obtaining an elongated implant, where the ratio of the diameter to the length on the implant axis constitutes between 1:20 and 1:40, for the controlled and delayed release of a GnRH analogue of triptorelin acetate. In addition, the group of inventions deals with the elongated implant, obtained in accordance with the said method.
EFFECT: group of inventions provides good control over triptorelin release from the implant.
11 cl, 26 ex, 6 dwg, 11 tbl
Authors
Dates
2015-04-27—Published
2010-04-29—Filed